Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier

International Journal of Pharmaceutics

Volumn 288, Issue 2, 2005, Pages 349-359

  Wang, Qing ^a   Rager, Joseph D ^a   Weinstein, Kathryn ^a   Kardos, Paula S ^a   Dobson, Glenn L ^a   Li, Jibin ^a   Hidalgo, Ismael J ^a  

^a Absorption Systems   (United States)

Author keywords

Blood brain barrier; Cell model; MDR MDCK; Permeability

Indexed keywords

AMITRIPTYLINE; ATENOLOL; BRETYLIUM TOSYLATE; CAFFEINE; CARBAMAZEPINE; CEFUROXIME; CHLOROTHIAZIDE; CHLORPROMAZINE; CLONIDINE; CYCLOSPORIN A; DESIPRAMINE; DIGOXIN; DIPYRIDAMOLE; DOXYLAMINE; ETOPOSIDE; FLUOXETINE; FUROSEMIDE; GUANFACINE; INDOMETACIN; LABETALOL; LINCOMYCIN; LOPERAMIDE; METHOTREXATE; PHENAZONE; QUINIDINE; RANITIDINE; RHODAMINE 123; SALAZOSULFAPYRIDINE; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE; DOGS; MALE; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 11144249849     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.10.007     Document Type: Article

References (43)

1. N.D. Barber, and J.L. Reid Comparison of the actions of centrally and peripherally administered clonidine and guanfacine in the rabbit: investigation of the differences Br. J. Pharmacol. 77 1982 641 647
2. R. Bendayan, G. Lee, and M. Bendayan Functional expression and localization of P-glycoprotein at the blood brain barrier Microsc. Res. Tech. 57 2002 365 380
3. 3H]dipyridamole Neurosci. Lett. 66 1986 341 345
4. J. Canena, J. Reis, A.S. Pinto, A.M. Santos, J. Leitao, T. Pinheiro, and M.G. Quina Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate J. Pharm. Pharmacol. 50 1998 279 283
5. D.J. Castro, S. Haghighat, R.E. Saxton, E. Reisler, N. Jongwaard, D.J. Castro, P.H. Ward, and R.B. Lufkin Biodistribution of rhodamine-123 in nude mice heterotransplanted with human squamous cell carcinomas Laryngoscope 102 1992 868 874
6. C. Crone, and S.P. Olesen Electrical resistance of brain microvascular endothelium Brain Res. 241 1982 49 55
7. R.G. del Moral, A. Olmo, M. Aguilar, and F. O'Valle P-glycoprotein: a new mechanism to control drug-induced nephrotoxicity Exp. Nephrol. 6 1998 89 97
8. L. Di, E.H. Kerns, K. Fan, O.J. McConnell, and G.T. Carter High throughput artificial membrane permeability assay for blood-brain barrier Eur. J. Med. Chem. 38 2003 223 232
9. M.J. Dresser, M.K. Leabman, and K.M. Giacomini Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters J. Pharm. Sci. 90 2001 397 421
10. F. Faassen, G. Vogel, H. Spanings, and H. Vromans Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs Int. J. Pharm. 263 2003 113 122
11. H. Franke, H. Galla, and C.T. Beuckmann Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro Brain Res. Prot. 5 2000 248 256
12. M. Gumbleton, and K.L. Audus Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier J. Pharm. Sci. 90 2001 1681 1698
13. I.J. Hidalgo Assessing the absorption of new pharmaceuticals Curr. Top. Med. Chem. 1 2001 385 401
14. D.M. Killian, L. Gharat, and P. Chikhale Modulating blood-brain barrier interactions of amino acid-based anticancer agents Drug Delivery 7 2000 21 25
15. H. Kourtopoulos, S.E. Holm, and B. Winblad The distribution of labeled antibiotics in normal and infected rat brain: an autoradiographic study Scand. J. Infect. Dis. 17 1985 395 400
16. G. Lee, L. Schlichter, M. Bendayan, and R. Bendayan Functional expression of P-glycoprotein in rat brain microglia J. Pharmacol. Exp. Ther. 299 2001 204 212
17. X. Liu, M. Tu, R.S. Kelly, C. Chen, and B.J. Smith Development of a computational approach to predict blood-brain barrier permeability Drug Metab. Dispos. 32 2004 132 139
18. J.M. Luco Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling J. Chem. Inf. Comput. Sci. 39 1999 396 404
19. S. Lundquist, M. Renftel, J. Brillault, L. Fenart, R. Cecchelli, and M.P. Dehouck Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models Pharm. Res. 19 2002 976 981
20. K.M. Mahar Doan, J.E. Humphreys, L.O. Webster, S.A. Wring, L.J. Shampine, C.J. Serabjit-Singh, K.K. Adkison, and J.W. Polli Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs J. Pharmacol. Exp. Ther. 303 2002 1029 1037
21. 18F]-l-m- tyrosine Synapse 52 2004 153 162
22. J.J. McNeil, and W.J. Louis Clinical pharmacokinetics of labetalol Clin. Pharmacokinet. 9 1984 157 167
23. N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of drug transporter studies on drug discovery and development Pharmacol. Rev. 55 2003 425 461
24. H. Murakami, H. Takanaga, H. Matsuo, H. Ohtani, and Y. Sawada Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique Am. J. Physiol. Heart Circ. Physiol. 279 2000 H1022 H1028
25. H. Ogasawara, T. Uozumi, K. Kiya, K. Kurisu, T. Mikami, T. Hotta, and K. Sugiyama Analysis and distribution of etoposide in rat brain tumor model: intracarotid versus intracarotid with angiotensin II-induced hypertension Cancer Invest. 11 1993 299 305
26. K.W. Otis, M.L. Avery, S.M. Broward-Partin, D.K. Hansen, H.W. Behlow Jr., D.O. Scott, and T.N. Thompson Evaluation of the BBMEC model for screening the CNS permeability of drugs J. Pharmacol. Toxicol. Methods 45 2001 71 77
27. T.J. Raub, S.L. Kuentzel, and G.A. Sawada Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells Exp. Cell Res. 199 1992 330 340
28. R.J. Rist, I.A. Romero, M.W. Chan, P.O. Couraud, F. Roux, and N.J. Abbott F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors Brain Res. 768 1997 10 18
29. R.D. Scheyer, M.J. During, D.D. Spencer, J.A. Cramer, and R.H. Mattson Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis Neurology 44 1994 1469 1472
30. A.H. Schinkel, E. Wagenaar, C.A. Mol, and L. van Deemter P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs J. Clin. Invest. 97 1996 2517 2524
31. G. Schreiber, and M. Sokolovsky Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses Mol. Pharmacol. 27 1985 27 31
32. M. Shadid, R. Moison, P. Steendijk, L. Hiltermann, H.M. Berger, and F. van Bel The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain Pediatr. Res. 44 1998 119 124
33. A. Sjo, K.E. Magnusson, and K.H. Peterson Distinct effects of protein kinase C on the barrier function at different developmental stages Biosci. Rep. 23 2003 87 102
34. Q.R. Smith, Y. Takasato, D.J. Sweeney, and S.I. Rapoport Regional cerebrovascular transport of leucine as measured by the in situ brain perfusion technique J. Cereb. Blood Flow Metab. 5 1985 300 311
35. Q.R. Smith Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system R.T. Borchardt Models for Assessing Drug Absorption and Metabolism 1996 Plenum Press New York pp. 285-307
36. J.A. Street, B.A. Hemsworth, A.G. Roach, and M.D. Day Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats Arch. Int. Pharmacodyn. Ther. 237 1979 180 190
37. Thakker, D.R., 2004. Strategic use of preclinical pharmacokinetics studies and in vitro ADME models in optimizing ADME properties. AAPS Workshop in Optimization of Drug-like Properties during Lead Optimization. Parsippany, NJ.
38. P.R. Twentyman Cyclosporins as drug resistance modifiers Biochem. Pharmacol. 43 1992 109 117
39. M. Uhr, T. Steckler, A. Yassouridis, and F. Holsboer Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption Neuropsychopharmacology 22 2000 380 387
40. G. Watt, G.W. Long, M. Grogl, and S.K. Martin Reversal of drug-resistant falciparum malaria by calcium antagonists: potential for host cell toxicity Trans. R. Soc. Trop. Med. Hyg. 84 1990 187 190
41. K. Weinstein, P. Kardos, R. Strab, and I.J. Hildaog Cultured epithelial cell assays used to estimate intestinal absorption potential R.T. Borchardt E.H. Kerns C.A. Lipinski D.R. Thakker B. Wang Pharmaceutical Profiling in Drug Discovery and Lead Selection 2004 AAPS Press Arlington, VA pp. 217-234
42. Z. Wu, P. Nybom, and K.E. Magnusson Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1 Cell Microbiol. 2 2000 11 17
43. J. Yang, and M. Aschner Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport Neurotoxicology 24 2003 741 745